Ligand validation:1PL0

AMZ: AMINOIMIDAZOLE 4-CARBOXAMIDE RIBONUCLEOTIDE

AMZ is a Ligand Of Interest in 1PL0 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
1PL0_AMZ_D_704	80%	10%	0.124	0.972	2.59	1.77	5	8	0	0	100%	1
1PL0_AMZ_B_702	78%	10%	0.13	0.974	2.62	1.79	5	7	1	0	100%	1
1PL0_AMZ_D_703	63%	8%	0.154	0.95	2.88	1.87	5	6	1	0	100%	1
5UZ0_AMZ_C_601	97%	52%	0.062	0.977	0.84	1.02	-	2	0	0	100%	1
5UY8_AMZ_D_602	91%	46%	0.091	0.976	0.85	1.22	1	2	0	0	100%	1
1P4R_AMZ_A_1701	79%	8%	0.134	0.979	2.83	1.8	6	5	0	0	100%	1
2CNQ_AMZ_A_1308	98%	50%	0.065	0.989	1.09	0.85	2	-	0	0	100%	1
2UV5_AMZ_A_1324	98%	52%	0.056	0.974	1.17	0.7	2	-	0	0	100%	1
4TX9_AMZ_A_302	96%	33%	0.067	0.978	1.23	1.43	2	5	0	0	100%	1
2R84_AMZ_B_401	93%	42%	0.081	0.974	1.29	0.97	2	2	0	0	100%	0.3
2R7K_AMZ_A_401	91%	37%	0.082	0.968	1.32	1.17	3	2	1	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.